Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
To apply for a patent
— Pharmaceutical researcher, USA
To know about pharmaceutical patents and their expiration dates
— Pharmaceutical R&D, Venezuela
For information on drug expiration / generic availability
— Pharmacist, USA
To get information on patent expiration dates, in particular composition patents
— Private equity, USA
For patent and exclusivity due dligience
— Pharma investment firm, USA
Generated: May 27, 2017
These international patent data are derived from patent families, based on US drug-patent linkages.
Accordingly, they should not be regarded as comprehensive records of ex-US drug-patent associations.
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8,586,630 | Mar 16, 2025 | Allergan | LUMIGAN | bimatoprost | |||||||||||||||||||||||||
| 9,155,716 | Mar 16, 2025 | Allergan | LUMIGAN | bimatoprost | |||||||||||||||||||||||||
| 9,241,918 | Mar 16, 2025 | Allergan | LUMIGAN | bimatoprost | |||||||||||||||||||||||||
| 8,309,605 | Mar 16, 2025 | Allergan | LUMIGAN | bimatoprost | |||||||||||||||||||||||||
| 8,278,353 | Mar 16, 2025 | Allergan | LUMIGAN | bimatoprost | |||||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
To gain information on when to expect generics on the market in order to inform patients of when they can expect more affordable drugs
— Retail pharmacist, USA
To identify patent expiration dates
— Medicine sourcing, Malaysia
To find expiration dates for patents on chemotherapy medicines
— Program manager, non-profit, USA
To identify Paragraph IV challenge opportunities and for product portfolio development
— Business development, China
For information about medicines -- patent expiration dates, title, terms, etc.
— Pharmaceutical regulatory affairs, Mexico
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
